INOVECA MEDTECHNA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,025,404 | 1,476,872 | 1,754,548 | 1,979,022 | 2,223,485 | 2,634,340 | 2,680,881 | 3,410,369 |
| Profit before tax | 2,464 | 4,496 | 41,478 | 56,307 | 23,549 | 37,424 | 109,005 | 91,257 |
| Net profit | 1,808 | 3,289 | 39,345 | 53,634 | 21,498 | 35,608 | 96,507 | 74,111 |
| Equity | 91,152 | 76,850 | 116,195 | 169,829 | 191,327 | 226,935 | 303,441 | 397,553 |
| Liabilities | 415,456 | 563,597 | 625,618 | 709,800 | 1,065,499 | 1,150,774 | 1,397,453 | 1,339,113 |
| Non-current assets | 29,378 | 22,978 | 46,980 | 60,778 | 53,457 | 74,365 | 262,371 | 191,176 |
| Current assets | 456,969 | 616,217 | 692,902 | 815,877 | 1,200,837 | 1,298,324 | 1,433,402 | 1,539,707 |
| Total assets | 486,347 | 639,195 | 739,882 | 876,655 | 1,254,294 | 1,372,689 | 1,695,773 | 1,730,883 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 387,500 | 517,845 | 643,255 |
| Social insurance contributions | - | - | - | - | - | 39,124 | 51,853 | 60,777 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +36.6% | +44.0% | +18.8% | +12.8% | +12.4% | +18.5% | +1.8% | +27.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.4% | 0.5% | 5.3% | 6.1% | 1.7% | 2.6% | 5.7% | 4.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.0% | 4.3% | 33.9% | 31.6% | 11.2% | 15.7% | 31.8% | 18.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.2% | 0.2% | 2.2% | 2.7% | 1.0% | 1.4% | 3.6% | 2.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.2% | 0.3% | 2.4% | 2.8% | 1.1% | 1.4% | 4.1% | 2.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.6 | 7.3 | 5.4 | 4.2 | 5.6 | 5.1 | 4.6 | 3.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 146,486 | 192,635 | 208,460 | 215,893 | 203,677 | 259,115 | 279,745 | 338,220 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
INOVECA MEDTECHNA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-12 | 2026-05-13 | 0.01 |
INOVECA MEDTECHNA - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-28 | 2025-04-28 | 16386.02 |
| 2024-12-30 | 2024-12-30 | 66719.15 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
INOVECA MEDTECHNA, UAB (code 123549952) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €3.41M, up from €2.68M in 2024 and €2.63M in 2023, showing a clear upward trend in sales. Revenue growth in 2025 was 27.2% year on year and 29.5% over two years. Net profit reached €74.1K in 2025, compared with €96.5K in 2024 and €35.6K in 2023, indicating that profitability remained positive despite a lower result than the prior year. The profit margin was 2.2% in 2025, after 3.6% in 2024 and 1.4% in 2023. Total assets increased to €1.73M, with equity at €397.6K and liabilities at €1.34M. The equity ratio was 23.0%, debt-to-equity stood at 3.37, and asset turnover was 1.97x. Return on equity was 18.6% and return on assets 4.3%. Revenue per employee was €341.0K and profit per employee €7.4K in 2025.